$SNGX Balance Sheet | Understand Stock

$SNGX

$0.36 +$0.01 (3.68%) Close

$SNGX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Contracts and grants receivable
Unbilled revenue
Research and development incentives receivable, current
Deferred issuance cost
Prepaid expenses and other current assets
Total current assets
Security deposit
Furniture and equipment, net
Right-of-use lease assets
Other assets
Research and development incentives receivable, net of current portion
Total assets

Liabilities and shareholders' equity
Current liabilities:
Accounts payable
Accrued expenses
Accrued compensation
Lease liabilities - current
Lease liabilities, current
Convertible debt
Deferred revenue, current
Total current liabilities

Non-current liabilities:
Convertible debt, net of debt discount of $92,067
Paycheck Protection Program loan, net of current
Lease liabilities, net of current
Convertible debt
Lease liabilities, net of current portion
Deferred revenue, net of current portion
Total liabilities
Series D preferred stock, $.001 par value; 0 and 50,000 shares authorized, none issued or outstanding as of December 31, 2023 and December 31, 2022, respectively
Shareholders' equity:
Preferred stock, 350,000 shares authorized; none issued or outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.001 par value; 75,000,000 shares authorized; 21,637,479 and 10,086,130 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Comments